Page last updated: 2024-11-02

oxymetazoline and Sleep Initiation and Maintenance Disorders

oxymetazoline has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Söderman, P1
Sahlberg, D1
Wiholm, BE1

Other Studies

1 other study available for oxymetazoline and Sleep Initiation and Maintenance Disorders

ArticleYear
[Nose drops can induce cerebral reactions in children].
    Lakartidningen, 1983, Sep-14, Volume: 80, Issue:37

    Topics: Age Factors; Brain; Child, Preschool; Female; Hallucinations; Humans; Imidazoles; Infant; Male; Oxym

1983